# Desensitization in Kidney Transplantation

> **NCT00908583** · PHASE4 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 44 (actual)

## Conditions studied

- HLA Sensitization

## Interventions

- **DRUG:** plasmapheresis
- **DRUG:** Bortezomib
- **DRUG:** Rituximab
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT00908583
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2016-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00908583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00908583, "Desensitization in Kidney Transplantation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00908583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*